Abstract
The effect produced by antibody specific to Candida albicans when attached to liposomes containing amphotericin B was studied in vivo. Liposomal amphotericin B bearing specific immunoglobulin (LAMB-Ab) was compared with the unencapsulated drug (fAMB) and other liposomal amphotericin B formulations in the short-term survival (21 days) of mice with disseminated candidiasis. Both the treatment and prophylaxis of the murine model of candidiasis were explored in these trials. LAMB-Ab increased survival rates in the model more than other liposomal preparations containing amphotericin B. Liposomal amphotericin B compounds as a group prolonged survival over fAMB. Liposomal preparations used for comparison included liposomes with attached nonspecific antibody (LAMB-Ab-), liposomes without antibody (LAMB), and liposomes with unattached specific antibody (LAMB+).
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Edwards J. E., Jr, Lehrer R. I., Stiehm E. R., Fischer T. J., Young L. S. Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med. 1978 Jul;89(1):91–106. doi: 10.7326/0003-4819-89-1-91. [DOI] [PubMed] [Google Scholar]
- Feld R., Bodey G. P., Rodriguez V., Luna M. Causes of death in patients with malignant lymphoma. Am J Med Sci. 1974 Aug;268(2):97–106. doi: 10.1097/00000441-197408000-00003. [DOI] [PubMed] [Google Scholar]
- GEHAN E. A. A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. Biometrika. 1965 Jun;52:203–223. [PubMed] [Google Scholar]
- Gregoriadis G., Senior J., Wolff B., Kirby C. Targeting of liposomes to accessible cells in vivo. Ann N Y Acad Sci. 1985;446:319–340. doi: 10.1111/j.1749-6632.1985.tb18411.x. [DOI] [PubMed] [Google Scholar]
- Heath T. D., Montgomery J. A., Piper J. R., Papahadjopoulos D. Antibody-targeted liposomes: increase in specific toxicity of methotrexate-gamma-aspartate. Proc Natl Acad Sci U S A. 1983 Mar;80(5):1377–1381. doi: 10.1073/pnas.80.5.1377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hospenthal D. R., Rogers A. L., Mills G. L. Development of amphotericin B liposomes bearing antibody specific to Candida albicans. Mycopathologia. 1988 Jan;101(1):37–45. doi: 10.1007/BF00455667. [DOI] [PubMed] [Google Scholar]
- Juliano R. L., Lopez-Berestein G., Hopfer R., Mehta R., Mehta K., Mills K. Selective toxicity and enhanced therapeutic index of liposomal polyene antibiotics in systemic fungal infections. Ann N Y Acad Sci. 1985;446:390–402. doi: 10.1111/j.1749-6632.1985.tb18416.x. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Lopez-Berestein G., Mehta R., Hopfer R. L., Mills K., Kasi L., Mehta K., Fainstein V., Luna M., Hersh E. M., Juliano R. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J Infect Dis. 1983 May;147(5):939–945. doi: 10.1093/infdis/147.5.939. [DOI] [PubMed] [Google Scholar]
- Szoka F. C., Jr, Milholland D., Barza M. Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B. Antimicrob Agents Chemother. 1987 Mar;31(3):421–429. doi: 10.1128/aac.31.3.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- YOUNG G. The process of invasion and the persistence of Candida albicans injected intraperitoneally into mice. J Infect Dis. 1958 Mar-Apr;102(2):114–120. doi: 10.1093/infdis/102.2.114. [DOI] [PubMed] [Google Scholar]